Moderna (NASDAQ: MRNA) reported Q4 EPS of ($2.11), $0.51 better than the analyst estimate of ($2.62). Revenue for the quarter came in at $678 million versus the consensus estimate of $662.84 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.